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Abstract
One-carbon metabolism (OCM) is linked to DNA synthesis and methylation, amino acid metabolism and cell proliferation.
OCM dysfunction has been associated with increased risk for various diseases, including cancer and neural tube defects.
MicroRNAs (miRNAs) are ,22 nt RNA regulators that have been implicated in a wide array of basic cellular processes, such
as differentiation and metabolism. Accordingly, mis-regulation of miRNA expression and/or activity can underlie complex
disease etiology. We examined the possibility of OCM regulation by miRNAs. Using computational miRNA target prediction
methods and Monte-Carlo based statistical analyses, we identified two candidate miRNA ‘‘master regulators’’ (miR-22 and
miR-125) and one candidate pair of ‘‘master co-regulators’’ (miR-344-5p/484 and miR-488) that may influence the expression
of a significant number of genes involved in OCM. Interestingly, miR-22 and miR-125 are significantly up-regulated in cells
grown under low-folate conditions. In a complementary analysis, we identified 15 single nucleotide polymorphisms (SNPs)
that are located within predicted miRNA target sites in OCM genes. We genotyped these 15 SNPs in a population of healthy
individuals (age 18–28, n=2,506) that was previously phenotyped for various serum metabolites related to OCM. Prior to
correction for multiple testing, we detected significant associations between TCblR rs9426 and methylmalonic acid (p =
0.045), total homocysteine levels (tHcy) (p = 0.033), serum B12 (p , 0.0001), holo transcobalamin (p , 0.0001) and total
transcobalamin (p , 0.0001); and between MTHFR rs1537514 and red blood cell folate (p , 0.0001). However, upon further
genetic analysis, we determined that in each case, a linked missense SNP is the more likely causative variant. Nonetheless,
our Monte-Carlo based in silico simulations suggest that miRNAs could play an important role in the regulation of OCM.
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Introduction
One-carbon metabolism (OCM) comprises a set of reactions
involving folate coenzymes and is critical for essential processes
including DNA methylation, cell proliferation, and the synthesis of
nucleic and amino acids. Insufficient folate or vitamin B12 intake,
genetic variation [1], or drug interference [2] can disrupt normal
OCM function. OCM dysfunction is linked to severe health
complications such as cancer [3,4], anemia [5] and neural tube
defects [6]. Folate-mediated OCM also influences levels of the
non-protein amino acid, homocysteine. Elevated homocysteine
levels have been linked to an increased risk for neural tube defects
[7]. Recent studies have revealed widespread changes in gene
expression under folate-deficient conditions [8]. However, the
underlying molecular mechanisms of these changes are poorly
understood.
MicroRNAs (miRNAs) are ,22 nucleotide non-coding RNAs
that regulate eukaryotic gene expression at the post-transcriptional
level [9]. Specifically, they associate with the RNA Induced
Silencing Complex (RISC) and guide it to target sites within
mRNAs. Once bound to mRNA, RISC induces gene repression
through a variety of mechanisms, including direct mRNA cleavage
and translational inhibition [10,11]. Most of the ,950 currently
known human miRNAs [12] are predicted to target hundreds of
genes, and many genes are targeted by multiple miRNAs [9,13].
miRNAs have been implicated in a wide array of fundamental
biological processes, such as development [14], lipid metabolism
[15], response to environmental stress [16] and innate immunity
[17]. Accordingly, mis-regulation of miRNA expression and/or
activity has been linked to many diseases including various cancers
and cardiovascular conditions [18], and is likely to underlie the
molecular etiology of many other disorders.
The role of miRNAs in the modulation of folate-mediated
OCM has not been extensively investigated. However, initial
studies suggest that folate influences miRNA expression; human
lymphoblastoid cells grown under folate-deficient conditions
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this observation, we examined the possibility of miRNA-mediated
regulation of the OCM pathway. Specifically, we applied a
computational strategy to predict whether any known human
miRNAs are candidate ‘‘master regulators’’ of the genes most
commonly associated with OCM. In a complementary analysis,
we also assessed whether genetic variants within predicted miRNA
target sites in OCM genes are associated with relevant metabolites.
Methods
miRNA target predictions
We used the TargetScanS 5.1 algorithm [20] for genome-wide
miRNA target prediction. Target predictions were filtered further
based on conservation of the miRNA and the 6–8 nt target site.
For our primary analyses, we defined conservation as precisely
shared nucleotide content between human and two of three other
mammalian species (rat, mouse and dog).
Discovery of candidate master miRNA regulators of OCM
genes
We implemented a Monte-Carlo algorithm to identify miRNAs
that are predicted to target 42 OCM genes significantly more than
expected by chance. First, we randomly selected 42 genes from the
human genome under the condition that they have at least one
predicted miRNA target site. Then we calculated the number of
genes from this randomly selected set that each known human
miRNA is predicted to target. By repeating this simulation 10,000
times, we generated a background distribution of the number of
predicted target genes for each miRNA, which we then used to
calculate an empirical p-value for the number of predicted OCM
target genes. We increased the number of simulations (up to
10,000,000) in specific instances in order to obtain a non-zero
empirical p-value. To account for differences in the average 39
UTR length between OCM genes and the randomly selected
genes in each simulation, we normalized the number of predicted
target genes to the average 39 UTR length.
The Trinity Student Study (TSS) Cohort
A population of 2,506 healthy, ethnically Irish individuals
consisting of students attending University of Dublin, Trinity
College and aged between 18 and 28 years old was recruited over a
period of one academic year (TSS cohort). Each participant
completed a questionnaire regarding intake of relevant supplements
and fortified foods, and gave 30 mL of blood. Genomic DNA was
extracted from all samples using a Qiagen QIAamp DNA Blood
Mini Kit or a Qiagen DNeasy Kit (Qiagen, UK). Serum folate, red
cellfolateandvitaminB12weremeasured bymicrobiologicalassays
as previously described [21,22]. Holotranscobalamin II (holoTC)
was directly measured with a commercial, monoclonal technique
(Abbott AxSYM, Microparticle Enzyme Immunoassay); total
transcobalamin II (total TC) was measured with the same technique
afterfirstsaturatingtheproteinwithcyanocobalamin.Levelsoftotal
homocysteine (tHcy), methionine, and methylmalonic acid (MMA)
weremeasuredatBevitalAS(www.bevital.no).Ethicalapprovalwas
obtained from the Dublin Federated Hospitals Research Ethics
Committee, which is affiliated with TCD and reviewed by the
Office of Human Subjects Research at the National Institutes of
Health. Written informed consent was obtained from the
participants before commencing the study.
SNP selection
To identify single nucleotide polymorphisms (SNPs) that might
influence miRNA targeting efficiency, we cross-referenced the
locations of all SNPs with a minor allele frequency . 0.05 from
HapMap Phase III [23] and dbSNP v131 [24] against the
locations of all predicted miRNA target sites in the 39 UTRs of 42
OCM-related mRNAs. This yielded 21 SNPs; however, due to
primer incompatibility with multiplex design or assay failure of the
original SNP, proxies (r
2 . 0.95) were selected for 3 of these SNPs.
In addition to these 21 SNPs in miRNA binding sites we also
tested two SNPs with previously reported functional relevance:
TCblR E88del [25] and MTHFR C677T [1].
Genotyping
Genotypes for all 21 variants were determined by allele-specific
extension product mass, detected via matrix-assisted laser
desorption/ionization – time of flight (MALDI-TOF) mass
spectrometry after undergoing iPlex assay chemistry (Sequenom,
San Diego, CA, USA). Primer sequences and assay conditions are
available upon request.
Out of the 21 variants, 19 were genotyped successfully, 17
passed quality control criteria, and 15 were confirmed as
polymorphic in our sample set and were tested for metabolite
associations. Individual assay quality was assessed based on call
rate, re-genotyping concordance and population fit to Hardy-
Weinberg equilibrium (HWE). Genotyping call rates (i.e., success
rates) averaged 97% for the TSS samples, and were at least 95%
for all accepted variants. More than 10% of TSS samples were
repeated with $98% concordance for all accepted variants. Only
one SNP (MTHFR rs1537514) was out of HWE (p,0.01). We
repeated the assay for rs1537514 using different extension primers,
and also separately genotyped a highly linked SNP (r
2=0.973;
MTHFR rs1537516), and found that both were out of HWE
(p=2.9610
25 and p=1.9610
24, respectively). While genotyping
error is generally the standard explanation for a SNP not adhering
to HWE, it is unlikely in this case due to the consistency across
three separate assays. These three assays displayed similar
measures of call rates and re-genotyping concordance; therefore,
MTHFR rs1537514 was retained for further analysis.
Statistical analysis
Analysis of variance (ANOVA) was used as the primary test to
evaluate each polymorphism for association with metabolite levels.
For each SNP, only metabolites that we predicted may be affected
based on the known biological function of the gene harboring the
SNP were tested. In cases where one genotype was too rare in our
sample set to analyze by ANOVA, the Student’s t-test was used to
compare the two genotypes present. Although some metabolic
datasets were not normally distributed, our large sample sizes
allowed the use of parametric tests as a screening tool. All
significant associations via parametric tests were recapitulated with
non-parametric tests (data not shown).
Results
We selected 42 genes (Table 1) known to be involved in the
OCM pathway to test in silico for miRNA targeting. In order to
minimize the rate of false positive miRNA target site predictions,
we used the TargetScanS 5.1 algorithm [20] which was recently
identified as one of the top performing prediction strategies [26],
and then further filtered the predictions to ensure that both the
miRNA and the predicted target site are conserved between
humans and at least two of three additional mammalian species
(rat, mouse and dog). The use of a conservation filter focuses the
analysis on putative miRNA regulation of OCM genes that may
be important enough to have persisted across ,80 million years of
evolution [27].
MicroRNAs and One-Carbon Metabolism
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OCM genes
Using these target predictions, we implemented a Monte-Carlo
algorithm to identify miRNAs that are predicted to target OCM
genes significantly more than expected by chance (Methods). The
analysis revealed that miR-22 is the top candidate master regulator
(p= 0.0126, Figure 1 and Table 2). Though not significant after
stringent Bonferroni correction for multiple testing, miR-22 is
predicted to have conserved targets in 4 important OCM genes:
SLC19A1, MAT2A, MTHFD2 and MTHFR. Notably, the last
three genes have at least one miR-22 target site that is conserved
among .5 vertebrates, including a predicted target site within
Table 1. Genes involved in one-carbon metabolism (OCM).
Symbol Function category HGNC Reference
AHCY Methylation cycle – regeneration of homocysteine 343 [38]
ALDH1L1 Distribution of one –carbon units 3978 [39]
AMT Distribution of one –carbon units -glycine cleavage 473 [40]
ATIC Purine biosynthesis - DNA synthesis 794 [41]
BHMT Homocysteine remethylation 1047 [42]
CD320 Vitamin B12 cellular receptor 16692 [43]
CUBN Vitamin B12 intestinal receptor 2548 [44]
DHFR Folate homeostasis 2861 [45]
DMGDH Distribution of one –carbon units 24475 [46]
DNMT1 DNA methylation 2976 [47]
DNMT3A DNA methylation 2978 [47]
DNMT3B DNA methylation 2979 [47]
FOLH1 Folate hydrolysis (intestinal) 3788 [48]
FOLR1 Cellular folate uptake 3791 [49]
FPGS Folate homeostasis 3824 [50]
FTCD Provision of one-carbon units – histidine catabolism 3974 [51]
GART Purine biosynthesis - DNA synthesis 4163 [52]
GGH Folate hydrolysis (lysosomal) 4248 [53]
GIF B12 absorbtion 4268 [44]
GNMT Glycine methylation – folate homeostasis 4415 [54]
MAT1A Synthesis of SAM - methylation 6903 [33]
MAT2A Synthesis of SAM - methylation 6904 [33]
MAT2B Synthesis of SAM - methylation, 6905 [33]
MMAB B12 metabolism 19331 [55]
MTFMT Mitochondrial protein synthesis –formyl-methionyl transfer 29666 [56]
MTHFD1 Distribution of one –carbon units 7432 [34]
MTHFD1L Distribution of one –carbon units 21055 [35]
MTHFD2 Distribution of one –carbon units 7434 [57]
MTHFD2L Distribution of one –carbon units 31865 [57]
MTHFR Distribution of one –carbon units 7436 [1]
MTHFS Distribution of one –carbon units 7437 [58]
MTR Homocysteine remethylation 7468 [59]
MTRR Homocysteine remethylation 7473 [60]
SARDH Distribution of one –carbon units 10536 [46]
SHMT1 Provision of one –carbon units -cytosol 10850 [61]
SHMT2 Provision of one –carbon units -mitochondrion 10852 [61]
SLC19A1 Reduced folate carrier 10937 [49]
SLC25A32 Mitochondrial folate transporter 29683 [62]
SLC46A1 Proton coupled folate transporter 30521 [49]
TCN1 B12 transport protein 11652 [28]
TCN2 B12 transport protein 11653 [28]
TYMS Thymidylate biosynthesis – DNA synthesis and repair 12441 [63]
For each gene, the gene symbol, known function, HGNC identification, and literature citations indicating involvement in OCM are provided.
doi:10.1371/journal.pone.0021851.t001
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th percentile according to the
TargetScanS scoring criteria. MTHFR also harbors four addi-
tional non-conserved miR-22 target sites, indicating a higher
likelihood of miR-22 targeting functionality.
We repeated the analysis with a less stringent conservation
requirement (among primates; human, rhesus, chimp) in order to
investigate whether any potential master regulators have arisen
recently in order to adapt to evolving physiology. This approach
predicts miR-22 target sites within two additional OCM genes,
TCblR and TCN2, which are involved in vitamin B12 uptake
[28]. However, because the liberal criteria leads to the prediction
of many more miR-22 target sites genome-wide, a large
proportion of which are likely false positives, the significance of
miR-22 targeting of OCM genes is diluted (p=0.1235). None-
theless, this less stringent analysis does indeed identify a different
candidate master regulator of OCM, miR-125/351, that may
have functional relevance in relatively recent evolutionary history
(p = 0.0033; Table S1).
miR-344-5p/484 and miR-488 are the top candidate
master co-regulators of OCM genes
miRNAs often co-regulate their target genes in order to induce
effective repression [13]. Accordingly, we implemented a Monte-
Carlo algorithm to identify pairs of miRNAs that are predicted to
co-target OCM genes significantly more than expected by chance.
miR-22 does not appear in the top 30 pairs of master co-regulator
candidates, suggesting that its influence upon OCM genes may
have evolved independently from that of other miRNAs. However,
we did identify miR-344-5p/484 and miR-488 as a candidate pair
for master co-regulators (p = 0.0004). Interestingly, though both
of these miRNAs are among the top 6 candidates for individual
candidate master regulators, neither is statistically significant by
itself (Table 2, Figure 1). That their targeting of OCM genes is
significant only when considered together as a pair suggests that
their influence upon OCM may have co-evolved.
Genotype-phenotype correlation analysis for
polymorphisms within predicted miRNA target sites in
OCM genes
In order to investigate the potential phenotypic relevance of the
predicted miRNA targeting of OCM genes, we first identified all
common HapMap Phase III and dbSNP v131 single nucleotide
polymorphisms (SNPs with minor allele frequency . 5%, n=21)
that map to within the predicted miRNA target sites. DNA
samples obtained from healthy Irish college students (n=2,506)
were genotyped at each SNP locus. Of these 21 SNPs, 14 were
successfully genotyped, and proxy SNPs (r
2 . 0.95) were
genotyped for 3 others. 15 of these 17 SNPs were polymorphic
in our sample set (Table S2). Blood, plasma and serum samples
from these same students were previously phenotyped for serum
metabolites related to OCM. We found significant associations
between 2 SNPs and several related metabolites: TCblR rs9426
with serum B12 (sB12) (p , 0.0001), holo transcobalamin
(holoTC) (p , 0.0001), total transcobalamin (total TC) (p ,
Figure 1. Statistical analysis of predicted microRNA targeting in the one-carbon metabolism (OCM) pathway. For each microRNA, the
empirical p-value for the level of enrichment of predicted target sites in OCM genes (Methods) is shown. Analysis is restricted to predicted target sites
that, together with their cognate microRNAs, are conserved between humans and at least two other mammalian species among mouse, rat and dog.
Lower dashed line indicates p=0.05; upper dashed line indicates equivalent significance level after correction for multiple hypothesis testing.
doi:10.1371/journal.pone.0021851.g001
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acid (MMA) (p = 0.045); and MTHFR rs1537514 with red blood
cell folate (RCF) (p , 0.0001) (Table 3; Table S2). Upon re-
analysis with only those participants who do not take vitamin
supplements (which can affect metabolite levels and may make a
genetic effect more difficult to detect), all associations remained
significant. After Bonferroni correction for multiple testing, the
TCblR rs9426 association with sB12, holoTC and total TC and
the MTHFR rs1537514 association with RCF remained signifi-
cant (Table 3).
TCblR rs9426 is in high D9 with another variant within the
TCblR gene, E88del (D9 = 0.94; r
2 = 0.37), which was
previously associated with increased levels of MMA in newborns of
European ancestry [25] and increased risk of neural tube defects
(NTD) in a large Irish population [29]. In order to compare the
effects of the two variants, we additionally genotyped E88del in
our cohort. Similar to rs9426, E88del displayed significant
associations with several metabolites: sB12 (p , 0.0001), holoTC
(p , 0.0001), total TC (p , 0.0001), tHcy (p , 0.011), and MMA
(p = 0.0016). However, the differences between alleles in the
average level of each of the 5 metabolites are greater for the
E88del locus than for rs9426. This observation supports the
hypothesis that the deletion of a glutamic acid residue at position
88 (E88del), rather than the removal of possible miRNA regulation
(rs9426), is the likely source of the metabolic variation observed
between genotypes.
MTHFR rs1537514 is in high D9 (D9=0.988; r
2 =0.059) with
the well-studied MTHFR 677C-.T (rs1801133; MAF=0.24) [1].
Both of these SNPs have minor allele frequencies in our cohort of
at least 0.11. We compared phenotypic variation of homozygotes
at each SNP locus independently. Specifically, as all MTHFR
C667T (SNP1) T (i.e. minor allele) alleles occur on a rs1537514
(SNP2) G (i.e. major allele) background, we compared the
following three genotype combinations by a two-tailed t-test:
(#1) SNP1 TT, SNP2 GG (n = 267); (#2) SNP1 CC, SNP2 GG
(n = 728); and (#3) SNP1 CC, SNP2 CC (n = 49). The results of
this analysis reveal that the major (#2) and minor allele (#1)
homozygotes of 677C-.T differ substantially more from one
another in RCF (204 nM difference between means, p , 0.0001)
than the major (#2) and minor (#3) allele homozygotes of
rs1537514 (152 nM difference between means, p = 0.0352). This
suggests that 677C-.T is more likely to be the causative variant.
Discussion
In this study we describe a computational strategy for the
identification of candidate master miRNA regulators of a group of
42 OCM-related genes. Based on our target prediction analyses
with the most stringent conservation criteria, we discover a novel
role for miR-22 as a candidate master regulator of OCM. miR-22
is widely expressed and has been previously linked to cancer
[30,31]. It is predicted to target OCM genes (MTHFR,
TCblR,TCN2, SLC19A1, MAT2A and MTHFD2) that are
critical for folate and vitamin B12 transport, folate cofactor
distribution and methylation (Table 1). The enzyme encoded by
the MTHFR gene plays a key role in the regulation of OCM by
channeling one-carbon units away from DNA synthesis and into
the production of methionine by MTR [32]. Methionine is then
converted to the methyl donor, S-Adenosyl methionine (SAM), by
Table 2. Top 6 candidate microRNA master regulators of one-
carbon metabolism genes in mammals.
microRNA
P-value for enrichment
of predicted target
sites in OCM genes
Predicted OCM
target genes
miR-22 0.0126 MTHFD2, MTHFR,
SLC19A1, MAT2A
miR-383 0.0286 SHMT2, DNMT3A
miR-344-5p/484 0.0787 DNMT3A, MAT2A
miR-136 0.08 MAT2A, MTHFS
miR-29abc 0.1024 DNMT3A, MAT2A,
DNMT3B, MAT1A
miR-488 0.1081 DNMT3A, MAT2A
For each microRNA, the empirical p-value for the level of enrichment of
predicted target sites in OCM genes (Methods) and the gene symbol for each
predicted target gene are provided. Analysis is restricted to predicted target
sites that, together with their cognate microRNAs, are conserved between
humans and at least two other mammalian species among mouse, rat and dog.
doi:10.1371/journal.pone.0021851.t002
Table 3. Summary metabolite data for individuals with different genotypes at significantly associated single nucleotide
polymorphic (SNP) loci that are within predicted microRNA target sites.
SNP Gene
Predicted
microRNA
binding site Genotype N
tHcy
(uM)
Met A
(uM) SB12 (pM)
Sfol
(nM) RCF (nM)
holoTC
(pM)
total TC
(pM)
MMA A
(uM)
rs9426 TCblR miR-136 CC 2192–
2246
*8.763.0 N/A **3286140 N/A N/A **57627 **8326163 *0.18860.0853
CT 198–
202
*8.262.5 N/A **3826190 N/A N/A **88652 **9756211 *0.17660.0721
TT 1 9.260 N/A 53860 N/A N/A 173601 3 0 7 60 0.14060
rs1537514 MTHFR miR-596
and miR-
518a-5p/527
GG 1926–
1946
8.763.1 29.668.5 N/A 34618 **10576422 N/A N/A N/A
GC 410–
414
8.462.5 28.667.6 N/A 35629 **11426470 N/A N/A N/A
CC 51 8.162.3 28.267.2 N/A 37623 **12696499 N/A N/A N/A
Numerical data represent mean metabolite levels 6SD; N indicates the range in the number of individuals with a particular genotype for which data was available for
different metabolites. * indicates a significant (p , 0.05) result; ** indicates a significant result (p , 0.05) after correction for multiple testing; N/A indicates that the SNP
was not test for association with a particular metabolite.
doi:10.1371/journal.pone.0021851.t003
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influences SAM production by regulating the activity of the B12-
dependent MTR enzyme. Folate is required for this process and is
transported from the circulation into cells by the reduced folate
carrier, the product of the SLC19A1 gene. Finally, MTHFD2 is
important for the exchange of one-carbon units between the
cytoplasm and the mitochondrion [34–35]. Coordinated regula-
tion of these genes by miR-22 is likely to influence OCM and
downstream epigenetic processes.
Our results revealed another potential master regulator of
OCM, miR-125/351. The large majority of its predicted targets
are conserved only in primates, indicating that its putative role in
regulating OCM may be more evolutionarily recent. It also
appears likely that while miR-125/351 functions cooperatively
with other miRNAs to impose regulation on OCM genes, miR-
229s influence in OCM may have evolved independently from
other miRNAs. Notably, both miR-22 and miR-125/351
significantly increase in expression upon folate deficiency [19],
lending further support to the prediction that these two miRNAs
are relevant to folate-mediated OCM. Our results suggest that
miR-344-5p/484 and miR-488 may act in a cooperative fashion to
regulate OCM. Neither miR-344-5p/484 nor miR-488 was
included in the Marsit et al. study that examined miRNA
expression under folate-deficient conditions. Future investigations,
including loss-of-function experiments using antagomirs [36] or
‘‘sponge’’ constructs [37] are required to validate the predicted
role of miR-22, miR-125/351, miR-344-5p/484 and miR-488 as
important regulators of OCM genes.
In a complementary, independent experiment, we genotyped 17
SNPs located within predicted miRNA target sites in OCM genes
and found significant associations between two of the SNPs and
several metabolites. However, further analyses suggested that these
associations could be accounted for by nearby functional variants
that are in strong linkage disequilibrium with the miRNA target
site SNPs. Nonetheless, we believe that our approach, which
combines bioinformatic and genetic experiments, provides a useful
model for exploring the role of miRNAs in basic physiological
processes.
Supporting Information
Table S1 Top 5 candidate microRNA master regulators
of one-carbon metabolism genes in primates. For each
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